cas 2097888-09-8|| where to buy 4-{[3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]sulfonyl}benzonitrile

Nom du produit:4-{[3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]sulfonyl}benzonitrile

IUPAC Name:4-{[3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]sulfonyl}benzonitrile

: CAS：2097888-09-8; Formule moléculaire：C19H16N4O3S; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2097888-09-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2097888-09-8; Formule moléculaire:C19H16N4O3S; Point de fusion:-; Code SMILES:O=S(=O)(N1CCC(C1)OC1=CN=C2C=CC=CC2=N1)C1=CC=C(C=C1)C#N; Densité:

: Numéro de catalogue:CM884080; Poids moléculaire:380.42; Point d'ébullition:; N° Mdl:; Stockage:

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.